| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT05476939 Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 |
Trial sites expanded: 50 -> 53 locations |
| 2026-08-06 | NCT05215106 Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast… |
overall status: Unknown → Active, Not Recruiting |
| 2026-08-06 | NCT05215106 Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast… |
date change Primary completion pushed: 2026-06 -> 2026-08-15 |
| 2026-08-06 | NCT05215106 Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast… |
date change Completion pushed: 2026-06 -> 2026-09-15 |
| 2026-08-05 | NCT07016230 Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced… |
Enrollment closed, study ongoing |
| 2026-08-05 | NCT07016230 Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced… |
date change Primary completion moved earlier: 2027-04-15 -> 2026-10-18 |
| 2026-08-02 | NCT05215106 Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT04823403 Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous… |
overall status: Recruiting → Unknown |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-10 | NCT07754006 Preliminary Clinical Feasibility Study of a Medical Device Enabling Brain Access Using… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06934057 | Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma | Kidney Cancer | Recruiting |
| Phase 3 | |||
| NCT06364631 | CARE1 Pragmatic Clinical Trial | Metastatic Kidney Cancer | Recruiting |
| NCT06332274 | tislelizUMaB in canceR Patients With molEcuLar residuaL Disease | Cancer | Recruiting |
| NCT05874063 | Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors | Germ Cell Tumor | Recruiting |
| NCT05692999 | Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a… | Metastatic Non-squamous Lung Cancer | Recruiting |
| NCT04221035 | High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | High-Risk Neuroblastoma | Recruiting |
| NCT06840782 | First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for… | Oligometastatic Non-small Cell Lung Cancer (NSCLC) | Recruiting |
| NCT06781996 | A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve… | Breast Cancer | Recruiting |
| NCT06402864 | Evaluation Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage… | Adult With Intermediate Low or Mid Rectal Adenocarcinoma | Recruiting |
| NCT06712472 | Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant… | Endometrial Cancer | Recruiting |
| NCT03983369 | Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children… | Mucositis Oral | Recruiting |
| NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant… | Prostate Cancer | Recruiting |
| NCT05476939 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | Diffuse Intrinsic Pontine Glioma | Recruiting |
| NCT01837745 | Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk… | Low Risk Differentiated Thyroid Cancer | Active, Not Recruiting |
| NCT07082452 | A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To… | Leukemia, B-Cell, Chronic | Not Yet Recruiting |
| NCT06787118 | Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of… | Breast Cancer Stage I | Not Yet Recruiting |
| NCT07431502 | Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated… | Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vulvar Site | Not Yet Recruiting |
| NCT03570021 | ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify… | Thyroid Cancer | Active, Not Recruiting |
| NCT02089100 | Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer | Breast Cancer | Active, Not Recruiting |
| NCT03519048 | Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy… | Head and Neck Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT07591467 | Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive… | BRCA-Mutated | Not Yet Recruiting |
| NCT07591493 | Adjuvant Trial in Pancreatic Neuroendocrine Tumors | Pancreatic Neuroendocrine Tumors (pNET) | Not Yet Recruiting |
| Phase 2 | |||
| NCT03406247 | Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT05631249 | Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With… | KRAS P.G12C | Recruiting |
| NCT04842162 | Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative… | Head and Neck Cancer | Recruiting |